Atomwise

February 22, 2022

Sold on the New Machine

In The News

Read Article

January 26, 2022

Atomwise bulks up executive team with Boehringer, Moderna, BridgeBio alums

FeaturedIn The News

Read Article

January 25, 2022

Atomwise Strengthens its Management Team, Adds Veteran Biopharma Leader David Thomson, Ph.D. as Chief Scientific Officer and Two Additional Senior Appointments

FeaturedPress Release

CSO, CFO, and GC added as technology-enabled pharma company bolsters growing management team and SAB SAN FRANCISCO, Calif. — January 25, 2022 — Atomwise, a leader in using artificial intelligence (AI) for small molecule drug discovery, announced today the appointment of David Thomson, Ph.D. as Chief Scientific Officer. Additional management team appointments include Jonathan Barr […]

Read Article

August 13, 2020

Atomwise Named to the 2020 CB Insights Digital Health 150 — List of Most Innovative Digital Health Startups

Press Release

Atomwise recognized for achievements in AI-driven drug discovery and creation of the AtomNet® platform, which has tackled — and succeeded in — finding small molecule hits for more undruggable targets than any other platform NEW YORK, August 13, 2020 — CB Insights today named Atomwise to its second annual Digital Health 150 ranking, which showcases […]

Read Article

September 27, 2019

Treating Parkinson’s by restoring a waste-clearing mechanism

In The News

Angus Liu of FierceBiotech reports on new research on Miro1 and implications for Parkinson’s disease.

Read Article

September 26, 2019

Potential diagnostic tool, treatment for Parkinson’s disease

In The News

Science Daily reports on a recent publication by researchers at Stanford, Mayo Clinic, and Atomwise.

Read Article